Doublecortin-like kinase 1 (DCLK1) was overexpressed in 27% of PRAD, 21% of CCRCC, 19% of both BRCA and UCEC cohorts, and 18% in MB tumors (FDR ≤ 0.021). Here, DCLK1 is linked to prostate adenocarcinoma.